Abstract
Selective inhibitors of the adenosine 5'-diphosphate pathway of platelet activation have been used rarely in children in the United States. We report the successful use of ticlopidine, together with aspirin, in a 7-month-old infant with Kawasaki disease complicated by a thrombus in a giant coronary aneurysm that failed to resolve with thrombolytic therapy. Kawasaki disease, coronary aneurysms, antithrombotic therapy, ticlopidine, children.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aspirin / therapeutic use*
-
Coronary Thrombosis / complications
-
Coronary Thrombosis / drug therapy*
-
Drug Therapy, Combination
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Infant
-
Male
-
Mucocutaneous Lymph Node Syndrome / complications*
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Ticlopidine / therapeutic use*
Substances
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Ticlopidine
-
Aspirin